Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M90,681Revenue $M26,095Net Margin (%)4.5Z-Score2.3
Enterprise Value $M93,213EPS $1.0Operating Margin %7.9F-Score4
P/E(ttm))84.0Cash Flow Per Share $0Pre-tax Margin (%)4.5Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %4.7Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %-16.2Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-44.3ROA % (ttm)2.1Higher Current Ratio y-yN
Dividend Yield %3.9Insider Buy (3m)0ROE % (ttm)5.6Less Shares Outstanding y-yN
Payout Ratio %287Shares Outstanding M1,263ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNDavid Dreman 2014-12-31 Reduce-0.51%$67.15 - $75.38
($71.66)
$ 71.790%Reduce -75.42%28,764
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$67.15 - $75.38
($71.66)
$ 71.790%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$67.15 - $75.38
($71.62)
$ 71.790%Reduce -52.51%19,900
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$68.49 - $76.31
($73.2)
$ 71.79-2%Sold Out0
AZNCharles Brandes 2014-06-30 Reduce-0.78%$62.45 - $81.09
($72.26)
$ 71.79-1%Reduce -71.06%386,058
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$62.45 - $81.09
($72.26)
$ 71.79-1%Sold Out0
AZNGeorge Soros 2014-06-30 Buy 0.08%$62.45 - $81.09
($72.26)
$ 71.79-1%New holding150,000
AZNMario Gabelli 2014-06-30 Buy 0.02%$62.45 - $81.09
($72.26)
$ 71.79-1%New holding40,400
AZNNWQ Managers 2014-06-30 Reduce-0.01%$62.45 - $81.09
($72.26)
$ 71.79-1%Reduce -24.55%64,475
AZNHOTCHKIS & WILEY 2014-03-31 Sold Out -0.93%$58.51 - $68.38
($64.41)
$ 71.7910%Sold Out0
AZNCharles Brandes 2014-03-31 Reduce-0.84%$58.51 - $68.15
($64.29)
$ 71.7910%Reduce -46.73%1,333,894
AZNDavid Dreman 2014-03-31 Add0.14%$58.51 - $68.38
($64.41)
$ 71.7910%Add 26.61%135,439
AZNJoel Greenblatt 2014-03-31 Buy 0.09%$58.51 - $68.38
($64.41)
$ 71.7910%New holding95,518
AZNDavid Dreman 2013-12-31 Reduce-0.34%$49.72 - $59.5
($54.28)
$ 71.7924%Reduce -40.32%106,975
AZNHOTCHKIS & WILEY 2013-12-31 Reduce-0.3%$49.72 - $59.5
($54.28)
$ 71.7924%Reduce -24.90%3,689,214
AZNCharles Brandes 2013-09-30 Add0.12%$47.88 - $52.08
($50.24)
$ 71.7930%Add 7.92%2,381,040
AZNHOTCHKIS & WILEY 2013-06-30 Add0.68%$47.22 - $53.01
($50.92)
$ 71.7929%Add 131.18%4,944,742
AZNJoel Greenblatt 2013-06-30 Sold Out -0.24%$47.22 - $53.01
($50.92)
$ 71.7929%Sold Out0
AZNNWQ Managers 2013-03-31 Buy 0.03%$44.67 - $50.06
($47.4)
$ 71.7934%New holding78,400
AZNCharles Brandes 2012-12-31 Buy 1.2%$44.34 - $48.9
($46.77)
$ 71.7935%New holding2,188,735
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$17330.18view

Press Releases about AZN :

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
    Regulus Therapeutics (RGLS) microRNA Therapeutic Milestone Payment, Dave & Buster's Entertainment (P Apr 08 2015 
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
    Merck Takes A Step Forward In The World Of Medicine Jan 16 2015 
    Brandes International Equity Fund Q3 Commentary Dec 23 2014 
    Blackhill Bets Almost Half of Portfolio on Williams-Sonoma Nov 10 2014 
    A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio Nov 09 2014 
    Steven Cohen Has a Track Record of Impressive Returns Jul 31 2014 
    I Believe AstraZeneca Is Fairly Valued Jul 16 2014 
    A Look at AstraZeneca’s New Drug on Diabetes May 22 2014 


    More From Other Websites
    Juno teams with AstraZeneca to explore new therapy, foot the bill for clinical trial Apr 23 2015
    AstraZeneca Braced For Investor Pay Protest Apr 23 2015
    Star manager Neil Woodford has '30 ideas ready to go' Apr 23 2015
    AstraZeneca, Juno latest to collaborate on immuno-oncology drugs Apr 23 2015
    AstraZeneca, Juno latest to collaborate on immuno-oncology drugs Apr 23 2015
    UK set-top box maker Pace bought by US firm for £1.4bn Apr 22 2015
    We expect $280M in revenue this year: BOX CEO Apr 22 2015
    Economic Sentiment up in the Eurozone: EWG up 0.88%, FEZ up 0.46% Apr 22 2015
    AstraZeneca announces updated progression free survival data for investigational non-small cell lung... Apr 22 2015
    Are Investors Betting On Pfizer Inc. Coming Back For AstraZeneca plc? Apr 22 2015
    US stocks sag; Teva bid for Mylan boosts pharma shares Apr 21 2015
    Dow falls but Teva bid for Mylan boosts pharma stocks Apr 21 2015
    Mylan's Lesson from Deal-Making's Past Apr 21 2015
    Psychiatrists With Ties to AstraZeneca Resign From Texas State Hospital Apr 21 2015
    AstraZeneca drug Lynparza shows promise in prostate cancer trial Apr 21 2015
    AstraZeneca drug Lynparza shows promise in prostate cancer trial Apr 21 2015
    7:01 am AstraZeneca and Bina Technologies, a member of the Roche Group (Apr 21 2015
    Bina Technologies and AstraZeneca Announce Collaborative Agreement for Global Deployment of Bina’s... Apr 21 2015
    Athersys Slumps as MultiStem Fails in Mid-Stage Study - Analyst Blog Apr 20 2015
    What This Top Dividend Portfolio Is Holding Now: Vodafone Group plc, British American Tobacco plc... Apr 20 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK